Lidocaine-esketamine infusion reduces movement-evoked pain and opioid consumption in hepatic resection patients
New drug combination reduces pain after liver surgery
This randomized controlled trial of 304 patients undergoing elective hepatic resections found that a lidocaine-esketamine infusion significa…
A new mix of lidocaine and esketamine may lower pain and opioid use for patients recovering from liver surgery during the first three days.
Intravenous Esketamine Reduces Oculocardiac Reflex Incidence During Pediatric Strabismus Surgery
Esketamine reduces heart rate drops during surgery for children
Esketamine administration significantly lowers oculocardiac reflex incidence and improves hemodynamic stability in children undergoing elect…
A new study shows that esketamine can help keep children's heart rates stable during eye surgery for crossed eyes.
Intranasal esketamine and intravenous ketamine provide the strongest evidence for treating depressive disorders
Ketamine and Esketamine Show Promise for Treatment-Resistant Depression
This narrative review evaluates various ketamine formulations for depressive disorders, finding the strongest evidence for intranasal esketa…
New evidence highlights how different forms of ketamine and esketamine may help patients struggling with treatment-resistant major depressiv…
Ketamine or esketamine may improve functional motor symptoms and dissociative seizures in functional neurological disorder
Ketamine may improve symptoms for people with functional neurological disorder
This systematic review examines the impact of ketamine and esketamine on functional neurological disorder (FND) symptoms. The review reports…
New evidence suggests ketamine could help manage motor symptoms and seizures in people living with functional neurological disorder.
Impact of Cognitive Behavioural Therapy on Exclusive Breastfeeding in Postpartum Depression
CBT may help new moms breastfeed exclusively
Cognitive behavioural therapy significantly improves exclusive breastfeeding rates in patients with postpartum depression compared to standa…
Cognitive behavioral therapy may boost exclusive breastfeeding in new moms with postpartum depression, a new analysis suggests.
Perioperative esketamine significantly reduces postoperative depressive symptom scores and short-term pain in breast cancer surgery
Esketamine may lower depression scores after breast cancer surgery
This meta-analysis of 1,515 patients found that perioperative esketamine significantly reduced postoperative depressive symptom scores at da…
New data suggests esketamine could help manage feelings of depression and some pain for patients undergoing breast cancer surgery.
Dexmedetomidine plus esketamine may reduce postoperative delirium and injury
Combined dexmedetomidine and esketamine may protect brain function after surgery
Perioperative combo of dexmedetomidine and esketamine lowers neuronal injury biomarkers and delirium risk in surgical patients.
A new analysis suggests a combination of two medications could lower the risk of confusion and protect brain health during and after surgery…
Gastrodin, intranasal insulin, and cognitive training show greatest preventive effectiveness for postoperative cognitive dysfunction after cardiac surgery
Insulin, Gastrodin, and Training May Protect Brain After Heart Surgery
A systematic review and Bayesian network meta-analysis of 46 RCTs (9,928 patients) ranked 20 strategies for preventing postoperative cogniti…
A review of 46 trials suggests certain drugs and cognitive training may help prevent confusion and memory loss after cardiac surgery.
Esketamine reduces 3-month postpartum depression incidence from 20.89% to 11.59% in primiparae
Trial shows esketamine reduces postpartum depression risk in new mothers
This randomized controlled trial of 322 primiparae found that a single dose of esketamine significantly reduced the incidence of postpartum …
A clinical trial suggests that a single dose of esketamine during C-section surgery may lower the risk of developing postpartum depression.
Intranasal esketamine provides rapid acute improvement and reduced relapse risk in treatment-resistant depression
Esketamine shows rapid relief for treatment resistant depression
This meta-analysis of randomized controlled trials evaluated intranasal esketamine plus an oral antidepressant for treatment-resistant depre…
A new nasal spray combined with oral antidepressants can provide faster relief and lower relapse risks for people with treatment-resistant d…
Esketamine added to propofol maintains discharge readiness during outpatient flexible bronchoscopy
Trial shows esketamine addition helps patients recover from bronchoscopy
This randomized non-inferiority trial of 246 adults undergoing elective outpatient flexible bronchoscopy found that adding esketamine (0.1 m…
Adding a low dose of esketamine to propofol may help patients recover faster and cough less during outpatient bronchoscopy procedures.
Esketamine bolus reduces PPD incidence at 6 weeks to 9.15% compared to 19.33% in saline
Trial shows Esketamine bolus reduces postpartum depression risk
This randomized controlled trial of 503 subjects without prenatal depression undergoing caesarean delivery found that esketamine bolus signi…
A new trial suggests that an esketamine bolus can reduce the risk of postpartum depression following a cesarean delivery.
All esketamine Articles
- Lidocaine-esketamine infusion reduces movement-evoked pain and opioid consumption in hepatic resection patients
- Intravenous Esketamine Reduces Oculocardiac Reflex Incidence During Pediatric Strabismus Surgery
- Intranasal esketamine and intravenous ketamine provide the strongest evidence for treating depressive disorders
- Ketamine or esketamine may improve functional motor symptoms and dissociative seizures in functional neurological disorder
- Impact of Cognitive Behavioural Therapy on Exclusive Breastfeeding in Postpartum Depression
- Perioperative esketamine significantly reduces postoperative depressive symptom scores and short-term pain in breast cancer surgery
- Dexmedetomidine plus esketamine may reduce postoperative delirium and injury
- Gastrodin, intranasal insulin, and cognitive training show greatest preventive effectiveness for postoperative cognitive dysfunction after cardiac surgery
- Esketamine reduces 3-month postpartum depression incidence from 20.89% to 11.59% in primiparae
- Intranasal esketamine provides rapid acute improvement and reduced relapse risk in treatment-resistant depression
- Esketamine added to propofol maintains discharge readiness during outpatient flexible bronchoscopy
- Esketamine bolus reduces PPD incidence at 6 weeks to 9.15% compared to 19.33% in saline
- Esketamine significantly reduces postoperative anxiety (SMD -1.23) and depressive symptoms (SMD -0.92) in adult patients
- Meta-analysis finds esketamine improves response in treatment-resistant depression with dose-dependent adverse events
- Systematic review and meta-analysis of intranasal esketamine for treatment-resistant depression in real-world settings
- Esketamine vs fentanyl for pediatric tonsillectomy pain shows comparable FLACC scores
- FDA Approves Spravato (esketamine) for Treatment-Resistant Depression and Depressive Symptoms with Acute Suicidal Ideation in Adults
- Observational study links esketamine-induced mystical experiences to depression improvement in 45 patients